Abstract
Mandibular advancement appliances (MAD) have long been used to treat OSA. Most of the international sleep medicine societies recommend MAD in mild and moderate OSA. Most studies with MAD exclude patients with severe OSA and include patients who failed other treatment modalities with significant source of bias.Cephalometric and BMI factors are often not factored while prescribing MAD. So we undertook a pilot study to evaluate the therapeutic efficacy of Thornton adjustable positioner (TAP), a titratable MAD in severe adult OSA cases. We have observed significant (p <.0001) improvement in Apnea-Hypopnea index and Epworth sleepiness scale. We concluded that factoring predictable cephalometric measurements, BMId≤30 Kg/m2, and mandibular protrusion of 70%; severe OSA can be effectively managed with TAP.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
